Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MYT Netherlands (NY:MYTE)

6.390 -0.510 (-7.39%)
Streaming Delayed Price Updated: 2:55 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MYT Netherlands

< Previous 1 2 3 4 Next >
UBS Upgrades This Luxury E-Commerce Company - Read Why
UBS analyst Kunal Madhukar upgraded MYT Netherlands Parent BV (NYSE: MYTE) (Mytheresa) to Buy from Neutral. Madhukar said he is optimistic about the company... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
Upgrades For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1.... 
Via Benzinga
Mytheresa to Participate in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
Expert Ratings For MYT Netherlands Parent
Within the last quarter, MYT Netherlands Parent (NYSE:MYTE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Earnings Scheduled For February 16, 2022
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million. 
Via Benzinga
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower Ahead Of Fed Minutes
US stocks opened on a downbeat note this morning following the release of several economic reports. 
Via Benzinga
Q2 FY22 Results: Mytheresa Reports Strong GMV Growth of 26.2% in Q2 FY22 and Increases Guidance for Full Fiscal Year 2022
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
From MYT Netherlands Parent B.V.
Via Business Wire
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-... 
Via Benzinga
MYT Netherlands Parent B.V. (MYTE) Q1 2022 Earnings Call Transcript
MYTE earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Q1 FY22 Results: Mytheresa Reports Strong GMV Growth of 29.7% in Q1 FY22 and Continued Strong Profitability
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces First Quarter Fiscal Year 2022 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
10 Biggest Price Target Changes For Thursday
Morgan Stanley lowered the price target on Bed Bath & Beyond Inc. (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX: 
Via Benzinga
MYT Netherlands Parent B.V. (MYTE) Q4 2021 Earnings Call Transcript
MYTE earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Mytheresa Clocks 36% Growth In Q4 Sales
MYT Netherlands Parent BV (NYSE: MYTE) or Mytheresa reported fourth-quarter FY21 sales growth of 36.1% year-on-year, to €162.4 million. Sales in the U.S... 
Via Benzinga
Q4, FY 2021 Results: Mytheresa Reports Another Quarter of Exceptional Net Sales Growth; Full FY 2021 Net Sales at €612.1 Million, a Growth of 36.2% Over Last Year and 61.5% Compared to Full FY 2019
From MYT Netherlands Parent B.V.
Via Business Wire
Earnings Scheduled For September 14, 2021
Companies Reporting Before The Bell • Boston Beer Co (NYSE:SAM) is projected to report earnings for its second quarter. • Core & Main (NYSE:CNM) is estimated... 
Via Benzinga
Mytheresa Announces Fourth Quarter and Full Fiscal Year 2021 Earnings Release and Conference Call
From Mytheresa
Via Business Wire
MYT Netherlands Parent B.V. (MYTE) Q3 2021 Earnings Call Transcript
MYTE earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Q3, FY 2021 Results: Mytheresa Reports Exceptional Net Sales Growth of 47.5% in Q3, FY 2021 Benefiting From the Accelerated Shift in Consumer Behavior Towards Digital and Increases Full Year Guidance
From MYT Netherlands Parent B.V.
Via Business Wire
Earnings Scheduled For May 18, 2021
Companies Reporting Before The Bell • Agrify (NASDAQ:AGFY) is expected to report quarterly loss at $0.31 per share on revenue of $5.80 million. • Calliditas... 
Via Benzinga
Mytheresa Announces Third Quarter Fiscal Year 2021 Earnings Release and Conference Call; Participating in Upcoming Investor Conference
From MYT Netherlands Parent B.V.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.